Digitisation | November 14, 2023
BioPhy launches AI platform to accelerate the drug development market
The company has raised US$4.5 million in funding for its AI operating system
The company has raised US$4.5 million in funding for its AI operating system
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes
Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
Subscribe To Our Newsletter & Stay Updated
